Michael Kaseta Liquidia Corp (LQDA) insider trading activity

Michael Kaseta is CFO and COO of Liquidia Corp. Currently has a direct ownership of 312,328 shares of LQDA, which is worth approximately $3.61 Million. The most recent transaction as insider was on Dec 02, 2024, when has been sold 1,091 shares (Common Stock) at a price of $11.51 per share, resulting in proceeds of $12,557. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 312K

0.84% 3M change

70.67% 12M change

Total Value Held $3.61 Million

Michael Kaseta Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2024	SELL Open market or private sale	$12,557 $11.51 p/Share	1,091 Reduced 0.35%	312,328 Common Stock
Nov 30 2024	BUY Exercise of conversion of derivative security	-	2,343 Added 0.74%	313,419 Common Stock
Oct 14 2024	SELL Open market or private sale	$43,240 $11.11 p/Share	3,892 Reduced 1.24%	311,076 Common Stock
Sep 03 2024	SELL Open market or private sale	$10,250 $9.5 p/Share	1,079 Reduced 0.34%	314,968 Common Stock
Aug 30 2024	BUY Exercise of conversion of derivative security	-	2,344 Added 0.74%	316,047 Common Stock
Jul 12 2024	SELL Open market or private sale	$48,942 $12.53 p/Share	3,906 Reduced 1.23%	312,389 Common Stock
Jun 03 2024	SELL Open market or private sale	$15,917 $14.55 p/Share	1,094 Reduced 0.34%	316,295 Common Stock
May 31 2024	BUY Exercise of conversion of derivative security	-	2,344 Added 0.73%	317,389 Common Stock
Apr 12 2024	SELL Open market or private sale	$45,722 $14.58 p/Share	3,136 Reduced 0.99%	315,045 Common Stock
Mar 18 2024	SELL Open market or private sale	$192,466 $15.82 p/Share	12,166 Reduced 3.68%	318,181 Common Stock
Mar 15 2024	BUY Exercise of conversion of derivative security	-	2,344 Added 0.7%	330,347 Common Stock
Jan 15 2024	BUY Grant, award, or other acquisition	-	50,000 Added 13.29%	326,250 Common Stock
Jan 11 2024	BUY Grant, award, or other acquisition	-	93,250 Added 25.24%	276,250 Common Stock
Nov 30 2023	BUY Exercise of conversion of derivative security	-	2,343 Added 1.26%	183,000 Common Stock
Aug 31 2023	BUY Exercise of conversion of derivative security	-	2,344 Added 1.28%	180,657 Common Stock
May 31 2023	BUY Exercise of conversion of derivative security	-	2,344 Added 1.31%	176,597 Common Stock
Feb 28 2023	BUY Exercise of conversion of derivative security	-	9,375 Added 5.11%	174,253 Common Stock
Jan 11 2023	BUY Grant, award, or other acquisition	-	124,667 Added 43.41%	162,544 Common Stock
Sep 13 2022	BUY Open market or private purchase	$47,920 $5.99 p/Share	8,000 Added 17.44%	37,877 Common Stock
Aug 31 2022	BUY Open market or private purchase	$9,442 $4.9 p/Share	1,927 Added 6.06%	29,877 Common Stock
May 31 2022	BUY Open market or private purchase	$74,987 $4.01 p/Share	18,700 Added 40.09%	27,950 Common Stock
Nov 10 2021	BUY Exercise of conversion of derivative security	-	9,250 Added 50.0%	9,250 Common Stock

Also insider at

ALIM

ALIMERA SCIENCES INC Healthcare

Director

HRTX

HERON THERAPEUTICS, INC. Healthcare

Michael Kaseta

CFO and COO

Morrisville, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LQDA shares.

Notify only if

Value

Insider Trading

Get notified when an Liquidia Corp insider buys or sells LQDA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Liquidia Corp

Track Activities on LQDA

Account